跳至主要内容
临床试验/ISRCTN87039596
ISRCTN87039596已完成不适用

A randomised controlled trial to evaluate whether zoledronate prevents bone loss in acute multiple sclerosis

orth Bristol NHS Trust (UK)0 个研究点目标入组 40 人开始时间: 2009年5月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 - 65 years (either sex) with a diagnosis of multiple sclerosis (MS)
  • 2. Acute flare up requiring treatment with a corticosteroid
  • 3. Able to attend for study investigations and assessments
  • 4. Willing and able to provide informed consent

排除标准

  • 1. Previous diagnosis of osteoporosis
  • 2. Bone therapy within previous 12 months
  • 3. Previous bisphosphonate therapy at any time
  • 4. Associated disorder that may affect bone metabolism
  • 5. Pregnancy
  • 6. Breastfeeding

研究者

发起方
orth Bristol NHS Trust (UK)

相似试验

Zoledronate to prevent bone loss in acute multiple... | 临床试验